Treatment of mammary and extramammary Paget's skin disease with topical imiquimod

Journal of Dermatological Treatment

Volumn 17, Issue 3, 2006, Pages 167-171

  Mirer, Ewa ^a   El Sayed, Fouad ^a   Ammoury, Alfred ^a   Lamant, Laurence ^a   Messer, Line ^a   Bazex, Jacques ^a  

^a CHU PURPAN   (France)

Author keywords

Aldara; Extramammary Paget's disease; Imiquimod; Mammary Paget's disease; Skin cancer; Topical treatment

Indexed keywords

CYTOKERATIN 7; IMIQUIMOD;

ADENOCARCINOMA; AGED; APOCRINE GLAND; APPLICATION SITE IRRITATION; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EPITHELIUM; EROSION; ERYTHEMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY; SKIN IRRITATION; SURVIVAL TIME; SYMPTOM;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GROIN; HUMANS; PAGET'S DISEASE, EXTRAMAMMARY; PAGET'S DISEASE, MAMMARY; SKIN NEOPLASMS;

EID: 33746614371     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630600788877     Document Type: Article

References (24)

1. Lloyd J, Flaganan AM. Mammary and extramammary Paget's disease. J Clin Pathol. 2000;53:742-9.
2. Rao VR, Henry DH. Extramammary Paget's disease. Community Oncology. 2004;1:109-15.
3. Smith KJ, Tuur S, Corvette D, Lupton GP, Skelton HG. Cytokeratin 7 staining in mammary and extramammary Paget's disease. Mod Pathol. 1997;10:1069-74.
4. Ohnishi T, Watanabe S. The use of cytokeratin 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol. 2000;142:243-7.
5. O'Connor WJ, Lim KK, Zalla MJ, Gagnot M, Otley CC, Ngyen TH, et al. Comparison of mohs micrographic surgery and wide excision for extramammary Paget's disease. Dermatol Surg. 2003;29:723-7.
6. Moreno-Arias GA, Conill C, Sola-Casas MA, Mascaro-Galy JM, Grimalt R. Radiotherapy for in situ extramammary Paget disease of the vulva. J Dermatolog Treat. 2003;14:119-23.
7. Watanabe Y, Hoshiai H, Ueda H, Nakai H, Obata K, Noda K. Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease. Int J Gynecol Cancer. 2002;12:304-7.
8. Arensmeier M, Theuring U, Franke I, Willgeroth C, Kuhne KH. Topical therapy of extramammary Paget's disease. Hautarzt. 1994;45:780-2.
9. Berman B, Sullivan T, De Araujo T, Nadji M. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol. 2003;149:59-61.
10. Navi D, Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J. 2004;10(1): 4.
11. Hober D, Ajram L, Chehadeh W, Lazrek M, Goffard A, Dewilde A, et al. Mécanismes de l'activité antivirale indirecte de l'imiquimod. Ann Biol Clin. 2005;63:155-63.
12. Urosevic M, Dummer R. Role of imiquimod in skin cancer treatment. Am J Clin Dermatol. 2004;5:453-8.
13. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol. 2003;139:1325-32.
14. Dummer R, Urosevic M, Kempf W, Hoek K, Hafner J, Burg G. Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol. 2003;149:57-8.
15. Vender RB, Goldberg O. Innovative uses of imiquimod. J Drugs Dermatol. 2005;4:58-63.
16. Meyer T, Nindl I, Schmook T, Ulrich C, Strerry W, Stockfleth E. Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br J Dermatol. 2003;149:9-14.
17. Berman B, Spencer J, Villa A, Poochareon V, Elgart G. Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream. Clin Exp Dermatol. 2003;28:36-8.
18. Zampogna JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2002;47:229-35.
19. Moyal Barracco M, Berville Levy S, Rouzier R, Paniel B, Saiag P. Traitement par imiquimod de la maladie de Paget vulvaire et peri-anale: étude pilote de 17 cas. Ann Dermatol Venereol. 2005;132:9S1-9S70.
20. Wang LC, Blanchard A, Judge DE, Lorincz AA, Medenica MM, Busbey S. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol. 2003;49:769-72.
21. Qian Z, Zeitoun NC, Shieh S, Helm T, Oseroff AR. Successful treatment of extramammary Paget's disease with imiquimod. J Drugs Dermatol. 2003;2:73-6.
22. Korman N, Moy R, Ling M, Matheson R, Smith S, McKane S, et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol. 2005;141:467-73.
23. Tulchinsky H, Zmora O, Brazowski E, Goldman G, Rabau M. Extramammary Paget's disease of the perianal region. Colorectal Dis. 2004;6:206-9.
24. Banerjee S, Chatterjee M, Chand K. Extramammary Paget's disease. Indian J Dermatol Venereol Leprol. 2005;71:417-20.